Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.
Michelle Olofsson, Walter Osika, Simon B. Goldberg, Peter S. Hendricks, Predrag Petrović, Tonya White, Cecilia U.D. Stenfors, Sankalp Chaturvedi, Otto Simonsson
Int J Drug Policy December 13, 2025 DOI: 10.1016/j.drugpo.2025.105105 via PubMed Central
Summary
AI-generated from the abstractA cross-sectional survey of 3,168 U.S. adults with lifetime psychedelic use found that most (87.9%) reported no difficulties. Among those who did, 6.4% experienced post-acute difficulties lasting more than one day, and 1.3% for more than one year. The most common difficulties were general anxiety, negative changes in self-concept, and social disconnection. Childhood adversity was associated with higher odds of psychedelic-related difficulties: individuals with 2, 3, or 4 or more adverse childhood experiences had roughly double to nearly triple the odds of difficulties compared to those with none. Those with 4 or more ACEs also had higher odds of difficulties persisting beyond one day or one week.
Study at a glance
| Characteristics | Cross-sectional mixed-methods study Qualitative Peer reviewed |
|---|---|
| Sample size | 3,168 |
| Population | U.S. adults with lifetime psychedelic use |
| Citations | 2 |
| Key finding | Childhood adversity is associated with higher odds of psychedelic-related difficulties, including persistent symptoms lasting more than one day or one week. |
Abstract
BACKGROUND: Naturalistic psychedelic use can result in a range of difficulties that impair social, occupational, and other important areas of functioning. Yet, the prevalence, phenomenology, and etiology of these outcomes remain poorly understood. Recent qualitative research has shown that individuals with long-term difficulties after psychedelic use sometimes attribute their challenges to childhood trauma. Further studies are needed to investigate these relationships. METHODS: In this cross-sectional mixed-methods study of U.S. adults with lifetime psychedelic use (n = 3168), we examined the prevalence, duration, and nature of psychedelic-related difficulties, as well as associations with adverse childhood experiences (ACEs). RESULTS: Of all participants (n = 3168), most (n = 2785, 87.9 %) reported no difficulties; 6.4 % (n = 203) reported post-acute difficulties that lasted for more than one day, and 1.3 % (n = 40) for more than one year. Among those who reported difficulties (n = 383), 47 % (n = 180) reported that their difficulties resolved in one day or less. The most frequently reported post-acute difficulties were general anxiety (33.9 %), negative changes in self-concept (25.9 %), and social disconnection (23.0 %). In covariate-adjusted regression models, 2 ACEs (aOR: 2.24, p = 0.007), 3 ACEs (aOR: 2.27, p = 0.006), and ≥4 ACEs (aOR: 2.84, p < 0.001) were associated with higher odds of psychedelic-related difficulties compared to 0 ACEs. ≥4 ACEs were also associated with higher odds of difficulties that lasted more than one day (aOR: 2.37, p = 0.015) and more than one week (aOR: 2.89, p = 0.042). CONCLUSION: There are a range of difficulties that can follow psychedelic use and childhood adversity may represent a risk factor for persistent adverse effects.